Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.4% |
| 2 | Technology | 3.32% |
| 3 | Consumer Discretionary | 2.87% |
| 4 | Financials | 2.84% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
CALL
Thermo Fisher Scientific
TMO
$220B
| $61.8M | 0.02% |
170,600
-27,400
| -14% | -$9.18M |
|
627
Berkshire Hathaway Class B
BRK.B
$1.09T
| $61.8M | 0.02% |
346,162
-150,496
| -30% | -$27.5M |
|
628
CALL
Western Digital
WDC
$168B
| $61.7M | 0.02% |
1,849,289
-160,083
| -8% | -$5.19M |
|
629
Zurn Elkay Water Solutions
ZWS
$8.41B
| $61.6M | 0.02% |
4,388,278
+2,098,664
| +92% | +$27.5M |
|
630
CALL
Illumina
ILMN
$29.1B
| $61.6M | 0.02% |
170,956
-25,700
| -13% | -$8.27M |
|
631
PUT
MongoDB
MDB
$38B
| $61.6M | 0.02% |
272,100
-122,000
| -31% | -$22.6M |
|
632
CALL
Expedia Group
EXPE
$39.4B
| $61.5M | 0.02% |
747,700
-36,300
| -5% | -$2.64M |
|
|
XYZ
633
Block Inc
XYZ
$49.9B
| $61.4M | 0.02% |
585,361
+179,747
| +44% | +$13.8M |
|
634
PUT
RTX Corp
RTX
$297B
| $61.4M | 0.02% |
996,300
+270,127
| +37% | +$16.9M |
|
635
US Bancorp
USB
$102B
| $61.3M | 0.02% |
1,664,009
-4,629,390
| -74% | -$165M |
|
636
CALL
Take-Two Interactive
TTWO
$45.2B
| $61.3M | 0.02% |
438,900
+176,800
| +67% | +$23.1M |
|
637
PUT
RH
RH
$3.4B
| $61M | 0.02% |
245,100
-50,200
| -17% | -$9.1M |
|
638
CALL
Workday
WDAY
$51B
| $61M | 0.02% |
325,500
-13,900
| -4% | -$2.25M |
|
639
Boston Properties
BXP
$11B
| $60.9M | 0.02% |
674,337
+290,760
| +76% | +$26.4M |
|
640
CALL
Capital One
COF
$137B
| $60.9M | 0.02% |
973,200
+638,500
| +191% | +$39.8M |
|
|
INFO
641
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $60.9M | 0.02% |
+806,650
| New | +$54.9M |
|
642
PUT
Royal Caribbean
RCL
$82.9B
| $60.8M | 0.02% |
1,208,600
+301,800
| +33% | +$13.7M |
|
643
Amcor
AMCR
$21.4B
| $60.6M | 0.02% |
1,186,724
-405,843
| -25% | -$18.9M |
|
644
Werner Enterprises
WERN
$2.31B
| $60.5M | 0.02% |
1,390,088
+293,280
| +27% | +$12.1M |
|
645
PUT
Vertex Pharmaceuticals
VRTX
$131B
| $60.4M | 0.02% |
208,000
+91,300
| +78% | +$24.8M |
|
|
ISBC
646
DELISTED
Investors Bancorp, Inc.
ISBC
| $60.3M | 0.02% |
7,092,462
+342,919
| +5% | +$2.89M |
|
|
PARA
647
PUT
DELISTED
Paramount Global Class B
PARA
| $60.2M | 0.02% |
2,581,400
+1,075,700
| +71% | +$20.7M |
|
648
PUT
Honeywell
HON
$74.2B
| $60.2M | 0.02% |
441,482
+154,906
| +54% | +$20.5M |
|
649
CALL
Elevance Health
ELV
$86.4B
| $60.1M | 0.02% |
228,500
-39,000
| -15% | -$10.4M |
|
650
Teleflex
TFX
$5.82B
| $60.1M | 0.02% |
165,069
-126,712
| -43% | -$43.8M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, down from 4% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.